Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD.
Weber M, Mera P, Casas J, Salvador J, Rodríguez A, Alonso S, Sebastián D, Soler-Vázquez MC, Montironi C, Recalde S, Fucho R, Calderón-Domínguez M, Mir JF, Bartrons R, Escola-Gil JC, Sánchez-Infantes D, Zorzano A, Llorente-Cortes V, Casals N, Valentí V, Frühbeck G, Herrero L, Serra D.
Weber M, et al. Among authors: zorzano a.
FASEB J. 2020 Sep;34(9):11816-11837. doi: 10.1096/fj.202000678R. Epub 2020 Jul 15.
FASEB J. 2020.
PMID: 32666604
Free article.